While much studies have shown that HIF1AN gene expression is downregulated in various cancers, including breast cancer, thyroid cancer, prostate adenocarcinoma, and uterine corpus endometrial carcinoma.81 Here, HIF1AN is linked to prostate adenocarcinoma.